A closer look at the healing duo: what each peptide does, what the research actually says, and how the cycle runs.
Primary Benefits
- May accelerate healing of tendons, ligaments, and muscle tissue
- Supports angiogenesis and vascular repair
- Promotes re-epithelialization and wound closure
- May improve joint recovery and post-surgical outcomes
- Potential benefits for gut and inflammatory conditions (BPC-157)
Mechanism of Action
BPC-157
- A gastric-derived peptide shown in animal models to enhance angiogenesis, fibroblast migration, and growth factor signaling.
- Modulates the nitric oxide (NO) system and upregulates VEGF, improving blood flow to injured tissue.
- May enhance tendon fibroblast GH receptor expression in vitro.
- References: Systematic review of BPC-157 in musculoskeletal healing (1993–2024); comprehensive review of pleiotropic effects; wound healing and NO system interactions.
TB-500 / Thymosin Beta-4 (Tβ4)
- Actin-binding peptide that promotes cell migration and angiogenesis.
- Enhances wound healing and tissue regeneration in multiple animal models.
- Human trials of topical Tβ4 (RGN-259) showed efficacy in ocular repair (dry eye, neurotrophic keratopathy).
- References: Ligament healing in rat medial collateral ligament; RGN-259 in dry eye (phase II/III); Tβ4 in myocardial infarction repair.
Dosing & Protocol
Subcutaneous (SQ) injection.
Wolverine Cycle dosing note: For the Wolverine Cycle kit, use the Wolverine dosing guide rather than general standalone BPC-157 or TB-500 references. The cycle schedule is BPC-157 500 mcg (25 units) plus TB-500 300 mcg (15 units), drawn together Monday to Friday morning, weekends off. The small-remainder tip is TB-500 20 units (400 mcg) on Mon, Wed, and Fri in weeks 4, 5, and 6.
- Reconstitution: BPC-157 – 5 mg vial → 2.5 mL bacteriostatic water; TB-500 – 5 mg vial → 2.5 mL bacteriostatic water
- Daily dose: BPC-157 – 250–500 mcg (12.5–25 units); TB-500 – 200–400 mcg (10–20 units). Peptides may be drawn into the same insulin syringe after separate reconstitution and injected together.
- Cycle: 5 days on / 2 days off. Duration: 4–6 weeks.
- Timing: Take in the morning on an empty stomach, at least 30 minutes before eating.
Potential Side Effects
- Both peptides lack large-scale human safety trials.
- Reported side effects (rare, anecdotal): injection-site redness, mild nausea, appetite increase.
- Unknown long-term safety in humans.
Who Is This Stack For?
- Individuals exploring regenerative or performance-supportive peptides for joint, tendon, ligament, or soft tissue recovery.
- Athletes and biohackers refer to this as the “Wolverine Stack,” but note:
- WADA Prohibited List: Both BPC-157 and TB-500 are banned for competitive athletes.
- FDA Category 2 Substances: Neither peptide is approved; BPC-157 is specifically flagged as unsafe for compounding.
Notes
- Many TB-500 products are not full-length thymosin beta-4 but short fragments (e.g., LKKTETQ, aa 17–23). Research findings for Tβ4 may not fully translate to TB-500.
- Most evidence is from animal studies. Human data for BPC-157 are limited to retrospective knee pain case series and historical trials in ulcerative colitis.
- Tβ4 (as RGN-259) has clinical data in ocular conditions but not systemic musculoskeletal applications.
- Peptide quality varies between sellers; Pep Hub publishes third-party lab results for every batch — find them in The Receipts and verify your lot with Check Your Vial.
References
- Chang CH, et al. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-19077. PubMed
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-780. PubMed
- Sikiric P, et al. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing. Curr Pharm Des. 2018;24(18):1990-2001. PubMed
- Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med. 2021;27(4):8-13. PubMed
- Xu B, et al. Thymosin β4 enhances the healing of medial collateral ligament injury in rat. Regul Pept. 2013;184:1-5. PubMed
- Sosne G, et al. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea. 2015;34(5):491-496. PubMed
Disclaimer
This article is for educational purposes only and is not intended to replace medical advice. Always follow the guidance of your healthcare provider when using peptides. If you experience concerning symptoms or bruising that does not improve, seek professional medical care.
Still have questions?
Live support is on WhatsApp, with agents available 10am–10pm.